286 related articles for article (PubMed ID: 17606858)
1. Effects of fenofibrate on cardiac remodeling in aldosterone-induced hypertension.
Lebrasseur NK; Duhaney TA; De Silva DS; Cui L; Ip PC; Joseph L; Sam F
Hypertension; 2007 Sep; 50(3):489-96. PubMed ID: 17606858
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor alpha-independent actions of fenofibrate exacerbates left ventricular dilation and fibrosis in chronic pressure overload.
Duhaney TA; Cui L; Rude MK; Lebrasseur NK; Ngoy S; De Silva DS; Siwik DA; Liao R; Sam F
Hypertension; 2007 May; 49(5):1084-94. PubMed ID: 17353509
[TBL] [Abstract][Full Text] [Related]
3. Effects of fixed-dose isosorbide dinitrate/hydralazine on diastolic function and exercise capacity in hypertension-induced diastolic heart failure.
Wilson RM; De Silva DS; Sato K; Izumiya Y; Sam F
Hypertension; 2009 Sep; 54(3):583-90. PubMed ID: 19620510
[TBL] [Abstract][Full Text] [Related]
4. Reactivation of peroxisome proliferator-activated receptor alpha in spontaneously hypertensive rat: age-associated paradoxical effect on the heart.
Purushothaman S; Sathik MM; Nair RR
J Cardiovasc Pharmacol; 2011 Sep; 58(3):254-62. PubMed ID: 21654328
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension.
Iglarz M; Touyz RM; Viel EC; Paradis P; Amiri F; Diep QN; Schiffrin EL
Hypertension; 2003 Oct; 42(4):737-43. PubMed ID: 12860836
[TBL] [Abstract][Full Text] [Related]
6. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
7. Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload.
Kuster GM; Kotlyar E; Rude MK; Siwik DA; Liao R; Colucci WS; Sam F
Circulation; 2005 Feb; 111(4):420-7. PubMed ID: 15687129
[TBL] [Abstract][Full Text] [Related]
8. Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.
Garcia AG; Wilson RM; Heo J; Murthy NR; Baid S; Ouchi N; Sam F
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H587-96. PubMed ID: 22730392
[TBL] [Abstract][Full Text] [Related]
9. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure.
Szabó Z; Magga J; Alakoski T; Ulvila J; Piuhola J; Vainio L; Kivirikko KI; Vuolteenaho O; Ruskoaho H; Lipson KE; Signore P; Kerkelä R
Hypertension; 2014 Jun; 63(6):1235-40. PubMed ID: 24688123
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure.
Sam F; Duhaney TA; Sato K; Wilson RM; Ohashi K; Sono-Romanelli S; Higuchi A; De Silva DS; Qin F; Walsh K; Ouchi N
Endocrinology; 2010 Jan; 151(1):322-31. PubMed ID: 19850745
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin type 2 receptor stimulation ameliorates left ventricular fibrosis and dysfunction via regulation of tissue inhibitor of matrix metalloproteinase 1/matrix metalloproteinase 9 axis and transforming growth factor β1 in the rat heart.
Lauer D; Slavic S; Sommerfeld M; Thöne-Reineke C; Sharkovska Y; Hallberg A; Dahlöf B; Kintscher U; Unger T; Steckelings UM; Kaschina E
Hypertension; 2014 Mar; 63(3):e60-7. PubMed ID: 24379181
[TBL] [Abstract][Full Text] [Related]
12. Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.
Matsusaka H; Ide T; Matsushima S; Ikeuchi M; Kubota T; Sunagawa K; Kinugawa S; Tsutsui H
Hypertension; 2006 Apr; 47(4):711-7. PubMed ID: 16505197
[TBL] [Abstract][Full Text] [Related]
13. The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload.
Meems LM; Cannon MV; Mahmud H; Voors AA; van Gilst WH; Silljé HH; Ruifrok WP; de Boer RA
J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):282-9. PubMed ID: 22800987
[TBL] [Abstract][Full Text] [Related]
14. A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone.
López-Andrés N; Martin-Fernandez B; Rossignol P; Zannad F; Lahera V; Fortuno MA; Cachofeiro V; Díez J
Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2372-82. PubMed ID: 21926338
[TBL] [Abstract][Full Text] [Related]
15. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
[TBL] [Abstract][Full Text] [Related]
16. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
[TBL] [Abstract][Full Text] [Related]
17. Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart.
Heymans S; Schroen B; Vermeersch P; Milting H; Gao F; Kassner A; Gillijns H; Herijgers P; Flameng W; Carmeliet P; Van de Werf F; Pinto YM; Janssens S
Circulation; 2005 Aug; 112(8):1136-44. PubMed ID: 16103240
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling.
Jia N; Dong P; Huang Q; Jin W; Zhang J; Dai Q; Liu S
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):262-6. PubMed ID: 18785976
[TBL] [Abstract][Full Text] [Related]
19. Structural, functional, and molecular alterations produced by aldosterone plus salt in rat heart: association with enhanced serum and glucocorticoid-regulated kinase-1 expression.
Martín-Fernández B; de las Heras N; Miana M; Ballesteros S; Delgado C; Song S; Hintze T; Cachofeiro V; Lahera V
J Cardiovasc Pharmacol; 2011 Jan; 57(1):114-21. PubMed ID: 20980916
[TBL] [Abstract][Full Text] [Related]
20. β1-Adrenergic blockers exert antioxidant effects, reduce matrix metalloproteinase activity, and improve renovascular hypertension-induced cardiac hypertrophy.
Rizzi E; Guimaraes DA; Ceron CS; Prado CM; Pinheiro LC; Martins-Oliveira A; Gerlach RF; Tanus-Santos JE
Free Radic Biol Med; 2014 Aug; 73():308-17. PubMed ID: 24933619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
